Human Longevity and Aging

India has 150 million+ people above the age 60 and there is a massive opportunity to keep them healthy & fit. But everyone’s focused on Gen Z and no one’s building for their parents. It’s a hard business but a big one. We’ve invested in two companies. Here’s why it’s tough and how one should crack it. Understand the reality first. 1. Elders don’t think of “health” as proactive. They’re conditioned to wait until something breaks before acting. You’re selling a solution to a problem they don’t know they have yet. 2. The 65-year-old needs it but their 35-year-old child pays for it. You're not selling to the elder. You’re selling to their guilt-driven kids in Gurgaon or US. The buyer ≠ the user. 3. Trust is everything and you don’t have it. Indian elders trust: Their doctor, astrologer & their neighbour Not apps. Not tech bros. Not AI. You can't growth hack trust. You earn it slowly, locally. 4. They don’t want new habits. They’ve had the same breakfast for 40 years. You’re not selling a product. You’re undoing decades of routine. 5. Distribution is hyperlocal. Elders don’t click Insta ads. They talk to the uncle in their colony. You scale building by building not by user cohorts. Yes, 150M+ elders. But it’s not one market. It’s a thousand tiny tribes. Different languages, cultures, food habits, family structures, and tech comfort levels. If it were easy, Tata or Reliance would’ve done it already. But it’s wide open now. The one who combines tech + trust + real care will win. So how do you crack it? 1. Think first principles & not trends Don’t build a “senior fitness app.” Ask: Why did they stop moving? What gives them joy? You’re selling independence, not health. 2. Design for peace, not features. One-click help, One daily routine, One trusted face. Great elder products feel like human care not software. 3. Human-first, tech-enable. Don’t replace the daughter. Support her. Train 100 amazing elder coaches. Build tools to help them scale. 4. Don't focus on CAC. Here, it’s about trust per acquisition. You’re not selling toothpaste. You’re asking to be let into their daily life. Start offline. Build trust then tech. 5. You’re in the business of habit change & not selling an app or a pill. Get them to walk 15 minutes a day. Add protein to breakfast. Laugh more. Sleep better. Small wins compound. Don’t build for scale first. Build for consistency. Be in the business of habit change. 6. This isn’t a hackable D2C play. It’s a decade-long trust business. Build for one community. Get to know 100 elders by name. Solve deep, boring problems with elegance. Everyone’s chasing the next billion youth users. But the hidden opportunity lies in serving the first 150 million elders. The elder care market in India isn’t just underserved. It’s misunderstood and needs long-term play. Founders who crack this will build generational companies.

Updated NICE menopause guidelines published today. While it’s welcome to see HRT as the preferred treatment for the menopause, this is a disappointing update overall. The focus remains primarily on vasomotor symptoms – hot flushes and night sweats – which are, for many women, not the main symptoms of perimenopause and menopause. Most women experience brain symptoms – brain fog, low mood, anxiety, poor concentration, sleep disturbances, memory problems and fatigue – and these are things we know are unlikely to be alleviated in the long term by CBT, as suggested. The guidelines also do not differentiate between older, synthetic HRT and the natural (body identical) hormones now more commonly prescribed – while the word “risk” is mentioned three times as often than the word “benefit”, these newer forms offer more benefit than risks. The true risk comes in NOT taking HRT at all, with good quality evidence showing that low hormones during menopause increases the risk of heart disease, osteoporosis, type 2 diabetes, dementia, neurodegenerative diseases, clincial depression, autoimmune diseases and an earlier death. These diseases reduce in women taking hormones and life expectancy increases. Women deserve to be fully informed and involved at every step of their healthcare consultation to make an informed decision on the right treatment or combination of treatments for them. While we have seen a rise in recent years in access to evidence-based treatments like HRT, a postcode lottery still exists, particularly for those from lower socio-economic backgrounds. Too many women are still struggling to receive HRT, and these guidelines will be confusing for both healthcare professionals and women. Perimenopause and menopause is sorely under-researched and under-funded, and this must change. In the meantime, women deserve to have a choice, and those who want to take HRT should be able to have it prescribed. That HRT is now the frontline treatment is refreshing, but future documents and consultations must go further to ensure women get the treatment they deserve. https://lnkd.in/enhp_EaS

Dr. Lisa Mosconi has been sounding the alarm for years and now the research is catching up. New findings are connecting menopause and Alzheimer’s in a way that can no longer be ignored. For decades, we assumed women were at higher risk simply because they lived longer. But the truth is more complex and more urgent. Dr. Mosconi’s work reveals that the drop in estrogen during menopause doesn’t just change our bodies. It changes our brains. Women aren’t just experiencing hot flashes and sleep issues. They’re experiencing real, measurable shifts in brain metabolism, often years before any cognitive symptoms are diagnosed. This isn’t just a women’s health issue. It’s a research gap. A funding gap. And a care gap. We need clinical trials that center women. Diagnostic tools that account for sex-based differences. And real conversations that treat menopause as the medical milestone it is, not a punchline. Because when we invest in understanding menopause, we’re not just improving midlife, we’re protecting the decades that come after it. Read the full article here: https://lnkd.in/eSWST54E

What is happiness, really? After 90 years of research, the longest study of human happiness ever conducted came to a three-word answer: Happiness is love. The study identified seven habits that separate happy-and-well at seventy from sad-and-sick at seventy. Six of them make the difference between getting to seventy and not. But only the seventh makes being seventy worth it. Here they are in order: First, don't smoke. A lifelong smoker has a 70% chance of dying from a smoking-related illness. There's no version of this that lands you in the happy column. Second, watch your substances. Half of your tendency toward addiction is inherited. People who develop dependencies don't end up happy; they end up divorced, sick, isolated. If there's history in your family, no use at all is the safest position. Third, eat sanely. The happy-old don't yo-yo. Anything restrictive enough to give you fast progress has a 95% failure rate. Fourth, move every day. The longest-lived populations on earth — Sardinia, Okinawa, Loma Linda — walk constantly. Walking is the human exercise of happiness. Fifth, build a coping practice. 16% of your waking life is negative emotion. The happy-old all have a method for processing it: meditation, therapy, prayer, journaling. The discipline matters more than the choice. Sixth, keep learning. Interest is a basic positive emotion. People who stop learning in their twenties become rigid by forty. Stay curious. Interrogate what you believe — and what you've made a habit of not believing. And the seventh — love. Real love. Not transactional. A marriage you've invested in. Friends who are there for you. People who would still know you if your career vanished. These take decades. But they make all the difference. Healthy habits get you to seventy. Love makes seventy worth it.

Demographic Profiles, 1953–2023. Population structure, mortality, and fertility mapped for countries around the world. Try the interactive visualization here: https://lnkd.in/dcpk4r_X The chart combines three demographic dimensions into a single profile: a population pyramid by age and sex, a mortality distribution, and a fertility profile showing where childbearing is concentrated by age group. Snapshots at ten-year intervals from 1953 to 2023 make it possible to trace how a country's demographic fingerprint has shifted over seven decades. From a visualization point of view the most challenging part was fitting three separate distributions into a single coherent graphic. The result is a three-armed layout, where each arm represents one dimension, meeting at a central location that anchors the selected country geographically. Data source: United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects 2024. The figures are modelled estimates derived from censuses, surveys, and vital statistics, harmonised to produce consistent time series across countries. #DataViz #OpenData #SpatialData #Demographics #PopulationData #UN #VisQuill

🔬 New evidence on how small lifestyle changes could add years to your life A new UK Biobank study followed 59,000 adults to find the minimum combined improvements in sleep, physical activity, and diet needed for meaningful gains in lifespan and healthspan. Key findings: → +1 year of life: Just 5 extra minutes of sleep, 2 minutes more physical activity, and half a serving of vegetables daily → +4 years disease-free: 24 minutes more sleep, 4 minutes more activity, plus modest diet improvements (one cup of vegetables, one serving of whole grains, two servings of fish weekly) → Optimal behaviors (7-8 hours sleep, 42+ min daily activity, quality diet) were linked to ~9.4 additional years of both lifespan and healthy years Practical takeaway: Small, simultaneous changes across sleep, movement, and nutrition may be more effective and sustainable than dramatic changes in any single area. Caveat: This is observational data showing associations, not causation. Diet was self-reported. Ref: Koemel et al. Minimum combined sleep, physical activity, and nutrition variations associated with lifeSPAN and healthSPAN improvements: a population cohort study. eClinicalMedicine, 2026

Doctors told millions of people their knee cartilage was gone for good. A small molecule just proved them wrong in mice—and in human tissue. Think about that. Osteoarthritis affects roughly 20% of the U.S. population. Millions of knee and hip replacements every year. For decades, the standard answer has been: manage the pain, delay the inevitable, replace the joint. The long-held assumptions:  ↳ Once cartilage wears down, it doesn't come back  ↳ Chondrocytes lose their regenerative capacity with age  ↳ Joint replacement is the only real solution for end-stage disease  ↳ Damage is permanent What Stanford researchers found instead:  ↳ An enzyme called 15-PGDH rises in aging joints and breaks down PGE2, a molecule that supports tissue repair  ↳ Block that enzyme, and existing cartilage cells reprogram toward a younger gene-expression profile  ↳ In aged mice, the drug regrew smooth, load-bearing hyaline cartilage—not scar tissue  ↳ After ACL-type injuries, treated mice kept thicker cartilage and better movement Here's the part that stopped me: Human cartilage from end-stage joint replacements—tissue that had clinically "failed"—responded to the same treatment in the lab. It started forming new articular cartilage. Tissue we'd written off still had dormant regenerative capacity. It just needed the right signal to wake up. The path forward: An oral version of this 15-PGDH inhibitor (MF-300) has already passed Phase 1 safety testing in humans for age-related muscle weakness. The same biological axis underlies both muscle and cartilage aging. No osteoarthritis patients have been treated yet. But the door is open. The ripple effect:  1 study proves cartilage can regenerate in aged tissue  10 replications means it's real  100 patients in trials means we learn if it works in humans  At scale = millions of people might keep their original knees We spent decades accepting that worn joints only get worse. This research asks a different question: what if the cells were waiting for permission to rebuild? Follow me, Dr. Martha Boeckenfeld, for breakthroughs where science rewrites what we thought was permanent. ♻️ Share if you believe regenerative medicine deserves more attention—and more funding. Sources: Blau, H. M., & Bhutani, N. (2026, January 3). Anti-aging injection regrows knee cartilage and prevents arthritis. SciTechDaily. Singla, M., Wang, Y. X., Monti, E., Bedi, Y., Agarwal, P., Su, S., Ancel, S., Hermsmeier, M., Devisetti, N., Pandey, A., Bakooshli, M. A., Palla, A. R., Goodman, S., Blau, H. M., & Bhutani, N. (2025). Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration. Science.

In one of the most touching moments of modern caregiving, hospital workers found a simple yet powerful way to comfort patients in complete isolation—by placing water-filled gloves in their hands, simulating human touch during their loneliest hours. Known as the “hand of God” technique, this act involved filling two medical gloves with warm water, tying them together, and gently placing them into a patient’s palms. For patients confined to COVID wards or intensive care units without family visits, the warmth and shape of the gloves offered something machines couldn’t—human connection. Many patients were unconscious or heavily sedated, but research has shown that touch—even simulated—can reduce anxiety, lower heart rates, and improve emotional response. For those battling not only illness but isolation, this gesture became a bridge between medical necessity and emotional humanity. It was a moment of compassion in the middle of crisis. No technology, no words, just the warmth of kindness captured in two gloves. Nurses and doctors said the results were immediate—patients seemed more relaxed, vital signs steadied, and spirits lifted even in silence. These gloves didn’t treat symptoms. They treated souls. They reminded everyone that healing isn’t just about medicine—it’s also about meaning, presence, and the quiet power of care. In the hardest days, small acts make the loudest echoes. #TechTime #fblifestyle #HumanKindness #HealingWithCompassion #HospitalHeroes #HumanityFirst #mentalhealthmatters

Speaking only one language is now identified as a risk factor for accelerated cognitive aging. A major new study in Nature Aging examining 86,149 people across 27 European countries just confirmed what many of us in bilingual education have long suspected—but with unprecedented rigor. Previous research showed bilinguals developed dementia later than monolinguals, but critics rightfully questioned whether this was really about language or other factors: immigration experiences, socioeconomic status, educational access. Fair concerns. This study controlled for all of them. The findings held across 27 countries, across different socioeconomic contexts, across various linguistic combinations. The more languages you speak, the better you age cognitively. But here's what stopped me: monolingualism itself emerged as a risk factor, while multilingualism showed protective effects in both cross-sectional and longitudinal analyses. The authors' recommendation? Include multilingualism in public health and educational frameworks. So when someone tells you "AI translation means nobody needs to learn languages anymore," consider what we're actually giving up: not just communication skills, but cognitive protection as we age. The technology is impressive. The long-term health consequences of linguistic atrophy? We're just beginning to understand them. For those of us researching bilingualism, this isn't just about academic outcomes—it's about lifelong cognitive health. That changes the conversation entirely.

The other day, I decided to run a little social experiment. I sat behind the scenes of a Zoom panel interview with someone over 50, not to interfere, just to observe. Because I wanted to see what ageism actually looks like in a “professional setting.” Spoiler alert: it’s not loud, it’s subtle and that’s what makes it worse. The second the camera turned on, I could feel it. Four smiling faces in perfect lighting, all younger than the candidate’s first email address. They said all the right things “We’re so glad you’re here!” but their tone gave away the subtext: We were hoping for someone younger. The first question hit like a warning shot. “How do you stay current with technology?” Translation: “Prove you’re not a fossil.” The candidate smiled, calm and confident, explaining how he’d led teams through multiple digital transitions and trained younger staff on new systems. But you could already see the polite nods, the kind people give when they’ve stopped listening and started deciding. Ageism doesn’t always sound like “You’re too old.” It sounds like “You might not fit our culture.” It hides behind phrases like “We want fresh energy” or “We’re looking for someone who can grow with us.” Translation: We want someone cheaper, greener, and easier to manage. At one point, a panelist who looked barely old enough to rent a car asked, “Where do you see yourself in five years?” He laughed softly and said, “Hopefully working for a company that values experience over assumptions.” You could feel the silence tighten like a Wi-Fi signal during a storm. Here’s the truth: people over 50 don’t struggle because they can’t adapt. They struggle because companies mistake experience for obsolescence. The same leaders who built systems that still keep businesses running are now being told they’re “not aligned with the future.” That’s funny, they invented the processes everyone else is now “innovating.” We keep hearing buzzwords like “diversity” and “inclusion,” but somehow age rarely makes the brochure. Everyone wants mentorship, just not from someone old enough to remember dial-up. We glorify “disruption” but ignore the people who know how to rebuild what gets broken. When the interview ended, the candidate smiled, thanked them sincerely, and logged off, fully aware that the rejection email was already drafted. That’s the cruel part of ageism: the calm dignity of someone who’s been told “no” by people who don’t yet realize how much they could learn from that very “no.” So yes, I ran an experiment and the result was predictable. Ageism isn’t about capability; it’s about insecurity. The modern job market doesn’t fear older workers because they’re outdated, it fears them because they’re competent. And nothing terrifies a fragile system more than experience that can’t be automated, the kind of wisdom you can’t fake in a webinar or replace with buzzwords about “innovation” from someone who’s never led through chaos.